<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37286327</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>07</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional observational study.</ArticleTitle><Pagination><StartPage>e069217</StartPage><MedlinePgn>e069217</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e069217</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2022-069217</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To describe self-reported characteristics and symptoms of treatment-seeking patients with post-COVID-19 syndrome (PCS). To assess the impact of symptoms on health-related quality of life (HRQoL) and patients' ability to work and undertake activities of daily living.</AbstractText><AbstractText Label="DESIGN">Cross-sectional single-arm service evaluation of real-time user data.</AbstractText><AbstractText Label="SETTING">31 post-COVID-19 clinics in the UK.</AbstractText><AbstractText Label="PARTICIPANTS">3754 adults diagnosed with PCS in primary or secondary care deemed suitable for rehabilitation.</AbstractText><AbstractText Label="INTERVENTION">Patients using the Living With Covid Recovery digital health intervention registered between 30 November 2020 and 23 March 2022.</AbstractText><AbstractText Label="PRIMARY AND SECONDARY OUTCOME MEASURES">The primary outcome was the baseline Work and Social Adjustment Scale (WSAS). WSAS measures the functional limitations of the patient; scores of &#x2265;20 indicate moderately severe limitations. Other symptoms explored included fatigue (Functional Assessment of Chronic Illness Therapy-Fatigue), depression (Patient Health Questionnaire-Eight Item Depression Scale), anxiety (Generalised Anxiety Disorder Scale, Seven-Item), breathlessness (Medical Research Council Dyspnoea Scale and Dyspnoea-12), cognitive impairment (Perceived Deficits Questionnaire, Five-Item Version) and HRQoL (EQ-5D). Symptoms and demographic characteristics associated with more severe functional limitations were identified using logistic regression analysis.</AbstractText><AbstractText Label="RESULTS">3541 (94%) patients were of working age (18-65); mean age (SD) 48 (12) years; 1282 (71%) were female and 89% were white. 51% reported losing &#x2265;1&#x2009;days from work in the previous 4 weeks; 20% reported being unable to work at all. Mean WSAS score at baseline was 21 (SD 10) with 53% scoring &#x2265;20. Factors associated with WSAS scores of &#x2265;20 were high levels of fatigue, depression and cognitive impairment. Fatigue was found to be the main symptom contributing to a high WSAS score.</AbstractText><AbstractText Label="CONCLUSION">A high proportion of this PCS treatment-seeking population was of working age with over half reporting moderately severe or worse functional limitation. There were substantial impacts on ability to work and activities of daily living in people with PCS. Clinical care and rehabilitation should address the management of fatigue as the dominant symptom explaining variation in functionality.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4201-1093</Identifier><AffiliationInfo><Affiliation>Department of Health and Community Sciences (Medical School), University of Exeter, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodfellow</LastName><ForeName>Henry</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-0979-2839</Identifier><AffiliationInfo><Affiliation>Department of Primary Care and Population Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pookarnjanamorakot</LastName><ForeName>Patra</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>General Medicine, Whittington Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8932-3695</Identifier><AffiliationInfo><Affiliation>Primary Care and Population Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bindman</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Research Department of Primary Care and Population Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blandford</LastName><ForeName>Ann</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3198-7122</Identifier><AffiliationInfo><Affiliation>UCLIC, Department of Computer Science, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bradbury</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Psychology, University of Southampton, Southampton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Belinda</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Research Department of Primary Care and Population Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Fiona L</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>Research Department of Primary Care and Population Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hurst</LastName><ForeName>John R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-7246-6040</Identifier><AffiliationInfo><Affiliation>UCL Respiratory, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hylton</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linke</LastName><ForeName>Stuart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research Department of Primary Care and Population Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfeffer</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricketts</LastName><ForeName>William</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-0475-0744</Identifier><AffiliationInfo><Affiliation>Respiratory Medicine, Barts Health NHS Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robson</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>10 Queen Street Place, London, EC4R 1AG, Living With Ltd, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevenson</LastName><ForeName>Fiona A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Research Department of Primary Care and Population Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sunkersing</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Research Department of Primary Care and Population Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jiunn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Applied Health Research, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomes</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Applied Health Research, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henley</LastName><ForeName>William</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-6273-2619</Identifier><AffiliationInfo><Affiliation>Department of Health and Community Sciences (Medical School), University of Exeter, Exeter, UK w.e.henley@exeter.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collaboration</LastName><ForeName>Living With Covid Recovery</ForeName><Initials>LWCR</Initials><AffiliationInfo><Affiliation>University College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NIHR132243</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anxiety disorders</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Depression &amp; mood disorders</Keyword><Keyword MajorTopicYN="N">MENTAL HEALTH</Keyword><Keyword MajorTopicYN="N">PRIMARY CARE</Keyword><Keyword MajorTopicYN="N">Public health</Keyword></KeywordList><CoiStatement>Competing interests: JB reports payments from University College London for working with the patient and public involvement group to prepare content for the digital health intervention since May 2020. KB's research portfolio is partly funded by National Institute for Health &amp;and Care Research (NIHR) Applied Research Collaboration Wessex. HG reports working as a clinical safety officer for Living With Ltd. JRH reports receiving personal fees and fees to institution for honorariums and consultancy payments from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline and Takeda, and also sponsorship for attending meetings from AstraZeneca and GlaxoSmithKline. HH reports payment from the University of East London for providing a lecture on long COVID and COVID-19 recovery in February 2021. SL reports grants from NIHR in which the payment was made to Camden and Islington NHS Trust between the period of October&#x2013;September 2022. PEP reports grants from the Medical Research Council and NIHR outside the submitted work. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>8</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>7</Day><Hour>21</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37286327</ArticleId><ArticleId IdType="pmc">PMC10335413</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2022-069217</ArticleId><ArticleId IdType="pii">bmjopen-2022-069217</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Excellence . COVID-19 rapid guideline: managing the long-term effects of COVID-19. 2022. Available: https://www.nice.org.uk/guidance/ng188</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Who coronavirus (COVID-19) dashboard 2022. 2022. Available: https://covid19.who.int/</Citation></Reference><Reference><Citation>Maxwell E, Poole R. NIHR themed review: living with covid19-second review: National Institute of health and care research. 2021. Available: https://evidence.nihr.ac.uk/themedreview/living-with-covid19-second-review/</Citation></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al. . n.d. Persistent symptoms following SARS-cov-2 infection in a random community sample of 508,707 people medrxiv 21259452. MedRxiv 10.1101/2021.06.28.21259452</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.28.21259452</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, et al. . Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun 2022;13:3528. 10.1038/s41467-022-30836-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics . Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. 2022. Available: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/7july2022</Citation></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021;38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Guida F, Polesel J, et al. . Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19). Int Forum Allergy Rhinol 2021;11:1685&#x2013;8. 10.1002/alr.22832</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22832</ArticleId><ArticleId IdType="pmc">PMC9291310</ArticleId><ArticleId IdType="pubmed">34109765</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, et al. . Risk factors for long COVID: analyses of 10 longitudinal studies and electronic health records in the UK. Epidemiology [Preprint]. 10.1101/2021.06.24.21259277</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.24.21259277</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler CX, Wyller VBB, Moss-Morris R, et al. . Long COVID and post-infective fatigue syndrome: a review. Open Forum Infect Dis 2021;8:ofab440. 10.1093/ofid/ofab440</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab440</ArticleId><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Greenhalgh T, Milne R, et al. . Are vaccines a potential treatment for long covid? BMJ 2022;377:988. 10.1136/bmj.o988</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o988</ArticleId><ArticleId IdType="pubmed">35584848</ArticleId></ArticleIdList></Reference><Reference><Citation>Torjesen I. Covid-19 patients discharged from hospital have "substantially higher risk'' of adverse outcomes and need monitoring. BMJ 2022;376:265. 10.1136/bmj.o265</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o265</ArticleId><ArticleId IdType="pubmed">35105538</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Covid-19: long covid risk is lower with omicron than delta, researchers find. BMJ 2022;377:1500. 10.1136/bmj.o1500</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o1500</ArticleId><ArticleId IdType="pubmed">35714995</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Pittet LF, Curtis N. Long covid in children and adolescents. BMJ 2022;376:143. 10.1136/bmj.o143</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o143</ArticleId><ArticleId IdType="pubmed">35058281</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones R, Davis A, Stanley B, et al. . Risk predictors and symptom features of long COVID within a broad primary care patient population including both tested and untested patients. Pragmat Obs Res 2021;12:93&#x2013;104. 10.2147/POR.S316186</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/POR.S316186</ArticleId><ArticleId IdType="pmc">PMC8366779</ArticleId><ArticleId IdType="pubmed">34408531</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med 2021;27:626&#x2013;31. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Waters T, Wernham T. Long COVID and the labour market: the Institute for fiscal studies. 2022.</Citation></Reference><Reference><Citation>England NHS, Improvement NHS. Long-COVID: the NHS plan for 2021/22 2021. 2021. 
Available: https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2021/06/C1312-long-covid-plan-june-2021.pdf</Citation></Reference><Reference><Citation>Thorlby R, Gardner T, Allen L, et al. . The NHS long term plan and COVID-19: assessing progress and the pandemic&#x2019;s impact. London: The Health Foundation, 2021.</Citation></Reference><Reference><Citation>Murray E, Goodfellow H, Bindman J, et al. . Development, deployment and evaluation of digitally enabled, remote, supported rehabilitation for people with long covid-19 (living with covid-19 recovery): protocol for a mixed-methods study. BMJ Open 2022;12:e057408. 10.1136/bmjopen-2021-057408</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-057408</ArticleId><ArticleId IdType="pmc">PMC8822541</ArticleId><ArticleId IdType="pubmed">35131836</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundt JC, Marks IM, Shear MK, et al. . The work and social adjustment scale: a simple measure of impairment in functioning. Br J Psychiatry 2002;180:461&#x2013;4. 10.1192/bjp.180.5.461</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.180.5.461</ArticleId><ArticleId IdType="pubmed">11983645</ArticleId></ArticleIdList></Reference><Reference><Citation>EuroQol Research Foundation . EQ-5D-5L userguide. 2019.</Citation></Reference><Reference><Citation>Ministry of Housing CaLG . English indices of deprivation 2019 research report; 2019.</Citation></Reference><Reference><Citation>Yorke J, Moosavi SH, Shuldham C, et al. . Quantification of dyspnoea using descriptors: development and initial testing of the dyspnoea-12. Thorax 2010;65:21&#x2013;6. 10.1136/thx.2009.118521</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2009.118521</ArticleId><ArticleId IdType="pmc">PMC2795166</ArticleId><ArticleId IdType="pubmed">19996336</ArticleId></ArticleIdList></Reference><Reference><Citation>Montan I, L&#xf6;we B, Cella D, et al. . General population norms for the functional assessment of chronic illness therapy (FACIT) -fatigue scale. Value in Health 2018;21:1313&#x2013;21. 10.1016/j.jval.2018.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2018.03.013</ArticleId><ArticleId IdType="pubmed">30442279</ArticleId></ArticleIdList></Reference><Reference><Citation>Piper BF, Cella D. Cancer-Related fatigue: definitions and clinical subtypes. J Natl Compr Canc Netw 2010;8:958&#x2013;66. 10.6004/jnccn.2010.0070</Citation><ArticleIdList><ArticleId IdType="doi">10.6004/jnccn.2010.0070</ArticleId><ArticleId IdType="pubmed">20870639</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestall JC, Paul EA, Garrod R, et al. . Usefulness of the medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581&#x2013;6. 10.1136/thx.54.7.581</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.54.7.581</ArticleId><ArticleId IdType="pmc">PMC1745516</ArticleId><ArticleId IdType="pubmed">10377201</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz LI, Garry K, Prete AM, et al. . Six-Month outcomes in patients hospitalized with severe COVID-19. J GEN INTERN MED 2021;36:3772&#x2013;7. 10.1007/s11606-021-07032-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07032-9</ArticleId><ArticleId IdType="pmc">PMC8341831</ArticleId><ArticleId IdType="pubmed">34355349</ArticleId></ArticleIdList></Reference><Reference><Citation>Paladini L, Hodder R, Cecchini I, et al. . The MRC dyspnoea scale by telephone interview to monitor health status in elderly COPD patients. Respir Med 2010;104:1027&#x2013;34. 10.1016/j.rmed.2009.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2009.12.012</ArticleId><ArticleId IdType="pubmed">20116231</ArticleId></ArticleIdList></Reference><Reference><Citation>Cella D, Lai J-S, Chang C-H, et al. . Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 2002;94:528&#x2013;38. 10.1002/cncr.10245</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cncr.10245</ArticleId><ArticleId IdType="pubmed">11900238</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer RL, Kroenke K, Williams JBW, et al. . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092&#x2013;7. 10.1001/archinte.166.10.1092</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.10.1092</ArticleId><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan M, Edgley K, DeHousx E. A survey of multiple sclerosis, part 1: perceived cognitive problems and compensatory strategy use. Can J Rehabil 1990;4:99&#x2013;105.</Citation></Reference><Reference><Citation>Julian LJ, Yazdany J, Trupin L, et al. . Validity of brief screening tools for cognitive impairment in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2012;64:448&#x2013;54. 10.1002/acr.21566</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.21566</ArticleId><ArticleId IdType="pmc">PMC3705711</ArticleId><ArticleId IdType="pubmed">22162414</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam R. Subjective measures of cognitive dysfunction in major depressive disorder. In: McIntyre RS, ed. Cognitive Impairment in Major Depressive Disorder: Clinical Relevance, Biological Substrates, and Treatment Opportunities. 2016: 242&#x2013;50. 10.1017/CBO9781139860567.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/CBO9781139860567.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Strine TW, Spitzer RL, et al. . The PHQ-8 as a measure of current depression in the general population. J Affect Disord 2009;114:163&#x2013;73. 10.1016/j.jad.2008.06.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2008.06.026</ArticleId><ArticleId IdType="pubmed">18752852</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatric Annals 2002;32:509&#x2013;15. 10.3928/0048-5713-20020901-06</Citation><ArticleIdList><ArticleId IdType="doi">10.3928/0048-5713-20020901-06</ArticleId></ArticleIdList></Reference><Reference><Citation>McKelvey RD, Zavoina W. A statistical model for the analysis of ordinal level dependent variables. The Journal of Mathematical Sociology 1975;4:103&#x2013;20. 10.1080/0022250X.1975.9989847</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0022250X.1975.9989847</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahra D, Qureshi A, Henley W, et al. . The work and social adjustment scale: reliability, sensitivity and value. Int J Psychiatry Clin Pract 2014;18:131&#x2013;8. 10.3109/13651501.2014.894072</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13651501.2014.894072</ArticleId><ArticleId IdType="pubmed">24527886</ArticleId></ArticleIdList></Reference><Reference><Citation>Hommel M, Trabucco-Miguel S, Joray S, et al. . Social dysfunctioning after mild to moderate first-ever stroke at vocational age. Journal of Neurology, Neurosurgery &amp; Psychiatry 2009;80:371&#x2013;5. 10.1136/jnnp.2008.157875</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2008.157875</ArticleId><ArticleId IdType="pubmed">19010942</ArticleId></ArticleIdList></Reference><Reference><Citation>Paracha N, Abdulla A, MacGilchrist KS. Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients. Health Qual Life Outcomes 2018;16:179. 10.1186/s12955-018-0994-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-018-0994-8</ArticleId><ArticleId IdType="pmc">PMC6134713</ArticleId><ArticleId IdType="pubmed">30208899</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourrahmat M-M, Kim A, Kansal AR, et al. . Health state utility values by cancer stage: a systematic literature review. Eur J Health Econ 2021;22:1275&#x2013;88. 10.1007/s10198-021-01335-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10198-021-01335-8</ArticleId><ArticleId IdType="pmc">PMC8526485</ArticleId><ArticleId IdType="pubmed">34125315</ArticleId></ArticleIdList></Reference><Reference><Citation>Acaster S, Dickerhoof R, DeBusk K, et al. . Qualitative and quantitative validation of the facit-fatigue scale in iron deficiency anemia. Health Qual Life Outcomes 2015;13:60. 10.1186/s12955-015-0257-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-015-0257-x</ArticleId><ArticleId IdType="pmc">PMC4434873</ArticleId><ArticleId IdType="pubmed">25980742</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K, Marsh EB. Chronic post-stroke fatigue: it may no longer be about the stroke itself. Clinical Neurology and Neurosurgery 2018;174:192&#x2013;7. 10.1016/j.clineuro.2018.09.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2018.09.027</ArticleId><ArticleId IdType="pubmed">30266010</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S-Y, Zang X-Y, Fu S-H, et al. . Factors related to fatigue in Chinese patients with end-stage renal disease receiving maintenance hemodialysis: a multi-center cross-sectional study. Renal Failure 2016;38:442&#x2013;50. 10.3109/0886022X.2016.1138819</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/0886022X.2016.1138819</ArticleId><ArticleId IdType="pubmed">26887433</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen KR, Ainsworth MA, Steenholdt C, et al. . Fatigue is a systemic extraintestinal disease manifestation largely independent of disease activity, chronicity, and nutritional deficiencies in inflammatory bowel disease on biologics. Scandinavian Journal of Gastroenterology 2022;57:1051&#x2013;7. 10.1080/00365521.2022.2060049</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365521.2022.2060049</ArticleId><ArticleId IdType="pubmed">35412932</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, et al. . Physical, cognitive, and mental health impacts of covid-19 after hospitalisation (phosp-covid): a UK multicentre, prospective cohort study. Lancet Respir Med 2021;9:1275&#x2013;87. 10.1016/S2213-2600(21)00383-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Heightman M, Prashar J, Hillman TE, et al. . Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals. BMJ Open Respir Res 2021;8:e001041. 10.1136/bmjresp-2021-001041</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001041</ArticleId><ArticleId IdType="pmc">PMC8587466</ArticleId><ArticleId IdType="pubmed">34764200</ArticleId></ArticleIdList></Reference><Reference><Citation>International Consortium for Health Outcomes Measurement (ICHOM) . Sets of patient-centered outcome measures. n.d.
Available: https://connect.ichom.org/patient-centered-outcome-measures/</Citation></Reference><Reference><Citation>Munblit D, Nicholson T, Akrami A, et al. . A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study. The Lancet Respiratory Medicine 2022;10:715&#x2013;24. 10.1016/S2213-2600(22)00169-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00169-2</ArticleId><ArticleId IdType="pmc">PMC9197249</ArticleId><ArticleId IdType="pubmed">35714658</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, et al. . Incidence, co-occurrence, and evolution of long-covid features: a 6-month retrospective cohort study of 273,618 survivors of covid-19. PLoS Med 2021;18:e1003773. 10.1371/journal.pmed.1003773</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobsen JC, Gluud C, Wetterslev J, et al. . When and how should multiple imputation be used for handling missing data in randomised clinical trials-a practical guide with flowcharts. BMC Med Res Methodol 2017;17:162. 10.1186/s12874-017-0442-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-017-0442-1</ArticleId><ArticleId IdType="pmc">PMC5717805</ArticleId><ArticleId IdType="pubmed">29207961</ArticleId></ArticleIdList></Reference><Reference><Citation>Devine BF, Foley N, Ward M. Women and economy. House of Commons Library, 2021.</Citation></Reference><Reference><Citation>The Department of Health and Social Care (DHSC) and Office for National Statistics (ONS) . Direct and indirect health impacts of COVID-19 in England: the Department of health and social care (DHSC) and office for national statistics (ONS). 2021.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>